Trial intelligence / Profile preview

Effect of Daikenchuto (TU-100) on GI Transit

NCT00871325Phase 2Completed

Sponsor
Tsumura & Co.
Start
Jun 2009
Primary completion
Dec 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial of daikenchuto in postoperative ileus (POI) (3 arms), sponsored by Tsumura & Co. Primary endpoints: Gastric emptying of solid, Colonic geometric center at 24 hours and 1 more. Started Jun 2009; status: completed.

02

Drugs

daikenchuto
03

Conditions

postoperative ileus (POI)

Beyond the preview

Go deeper on NCT00871325.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00871325.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call